Axon CEO sells 10,000 shares in planned trade

Axon Enterprise CEO Patrick W. Smith reported an open-market sale of 10,000 shares of common stock at a weighted average price of $500.0018 per share on the reported transaction date.

Rhea-AI Filing Summary

Axon Enterprise CEO Patrick W. Smith reported an open-market sale of 10,000 shares of common stock at a weighted average price of $500.0018 per share on the reported transaction date. The sale was executed under a pre-arranged Rule 10b5-1 trading plan adopted on May 12, 2025.

Following this transaction, Smith directly holds 3,050,997 shares of Axon Enterprise common stock. The sale was carried out in multiple trades within a price range of $500.00 to $500.18, with the reported price reflecting the weighted average.

Insider Trade Summary 10b5-1

Net Seller: 10,000 shares

Net Sell 1 txn

Insider SMITH PATRICK W

Role CHIEF EXECUTIVE OFFICER

Sold 10,000 shs ($5.00M)

Type	Security	Shares	Price	Value
Sale	Common Stock	10,000	$500.0018	$5.00M

Holdings After Transaction: Common Stock — 3,050,997 shares (Direct)

Footnotes (2)

1. F1. The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 12, 2025.
2. F2. The transaction was executed in multiple trades at prices ranging from $500.00 to $500.18. The price reported above reflects the weighted average sales price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Key Figures

Shares sold: 10,000 shares Weighted average sale price: $500.0018 per share Post-transaction holdings: 3,050,997 shares +2 more

5 metrics

Shares sold 10,000 shares Open-market sale of common stock

Weighted average sale price $500.0018 per share Sale of 10,000 shares

Post-transaction holdings 3,050,997 shares Shares directly held after sale

Trade price range $500.00 to $500.18 Multiple executions within the sale

10b5-1 plan adoption date May 12, 2025 Date CEO adopted trading plan

Key Terms

Rule 10b5-1 trading plan, open-market sale, weighted average sales price, Form 4

4 terms

Rule 10b5-1 trading plan regulatory

"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 12, 2025."

A Rule 10b5-1 trading plan is a pre-arranged schedule that allows company insiders to buy or sell stock at specific times, even if they have inside information. It helps prevent accusations of unfair trading by making these transactions look planned and transparent, rather than sneaky or illegal.

open-market sale financial

"transaction_action": "open-market sale""

An open-market sale is when a shareholder sells existing shares directly on a public exchange to any willing buyer, rather than through a private deal. Think of it like putting goods on a busy market stall where price is set by supply and demand; for investors it matters because such sales increase available supply, can put short-term downward pressure on the stock price, and signal changes in liquidity or investor confidence.

weighted average sales price financial

"The price reported above reflects the weighted average sales price."

Form 4 regulatory

"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan..."

Form 4 is a official document that company insiders, such as executives or major shareholders, file with regulators whenever they buy or sell company shares. It provides transparency about how those with inside knowledge are trading, helping investors see if insiders are confident in the company's prospects or may be selling for personal reasons. This information can influence investor decisions by revealing insiders' perspectives on the company's value.

FAQ

What insider transaction did Axon (AXON) report for CEO Patrick W. Smith?

Axon reported that CEO Patrick W. Smith sold 10,000 shares of common stock in an open-market transaction. The sale was executed at a weighted average price of $500.0018 per share and was conducted under a pre-arranged Rule 10b5-1 trading plan.

At what price did the Axon (AXON) CEO sell his 10,000 shares?

The CEO’s 10,000 shares were sold at a weighted average price of $500.0018 per share. The trades occurred in multiple executions within a price range of $500.00 to $500.18, with the reported figure representing the overall weighted average sale price.

How many Axon (AXON) shares does CEO Patrick W. Smith hold after the sale?

After the reported sale, CEO Patrick W. Smith directly holds 3,050,997 shares of Axon common stock. This figure reflects his position immediately following the 10,000-share open-market sale disclosed in the Form 4 insider trading report.

Was the Axon (AXON) CEO’s stock sale made under a Rule 10b5-1 plan?

Yes. The filing states the transactions were effected under a Rule 10b5-1 trading plan adopted by Patrick W. Smith on May 12, 2025. Such plans allow pre-scheduled trades, which can make the timing less indicative of the insider’s short-term views.

What type of insider transaction did the Axon (AXON) Form 4 disclose?

The Form 4 disclosed a non-derivative open-market sale of common stock by the CEO. The transaction code was “S,” indicating a sale in the open market or a private transaction, and covered 10,000 shares at a weighted average sale price of $500.0018.

How many shares did the Axon (AXON) CEO sell according to the latest Form 4?

The CEO sold 10,000 shares of Axon common stock in this reported transaction. All shares were sold in an open-market transaction at prices between $500.00 and $500.18, resulting in a weighted average sale price of $500.0018 per share.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 06/30/2026 - 04:58 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

X

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

SMITH PATRICK W

(Last) (First) (Middle)

17800 NORTH 85TH STREET

(Street)

SCOTTSDALE ARIZONA 85255

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
AXON ENTERPRISE, INC. [ AXON ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	CHIEF EXECUTIVE OFFICER

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
06/29/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	06/29/2026		S(1)		10,000	D	$500.0018(2)	3,050,997	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 12, 2025.

2. The transaction was executed in multiple trades at prices ranging from $500.00 to $500.18. The price reported above reflects the weighted average sales price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Remarks:

	/s/ Patrick W. Smith by Isaiah Fields, Attorney-in-Fact	06/30/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)